Intentar ORO - Gratis
Transforming Diagnostics and Personalized Medicine Amidst Challenges
The Business Guardian
|December 29, 2024
Genomic testing, an advanced diagnostic tool, delves deep into the analysis of DNA, RNA, and proteomics to uncover genetic mutations, assess disease risks, and provide critical insights for medical decisions.
The field has seen transformative progress with the advent of technologies like next-generation sequencing, enabling the early detection of diseases, particularly cancers.
This cutting-edge approach has significantly enhanced diagnostic precision, making it a cornerstone in personalized medicine. However, challenges persist. Restricted insurance coverage, high costs, and the complexity of interpreting vast genomic data continue to hinder its widespread adoption.
These obstacles underscore the need for robust frameworks to ensure accessibility and affordability.
To shed light on this evolving field and its implications for healthcare, we turn to Dr. Kirti Chadha, Chief Scientific and Innovation Officer at Metropolis Healthcare Limited.
Q: What is genomic testing, and how does it differ from traditional diagnostic tests?
A: In 2003, the Human Genome Project that mapped an understanding of all human genes was completed and changed the entire testing scope impacting every clinical segment. Although genetic testing started way back in 1950 when Down (trisomy 21) and other syndromes were diagnosed by cytogenetic methods & evolved further in 1990s when the novel technique of PCR accelerated molecular genetic testing by enabling targeted testing for known pathogenic variants, it accelerated only when Next Generation Sequencing & other newer technologies added to the understanding of the human genome and its impact on disease.
Testing has now evolved from comprehensive gene panels to exome and genome sequencing as routine tests, thereby revolutionizing the diagnosis of rare genetic diseases among others.
As compared to traditional lab tests, genomic tests that study DNA, RNA, proteomics can identify mutations in our genes indicating if we have or not a genetic condition while also identifying our risk for developing a certain condition or passing on a genetic disorder to the next generation.
Esta historia es de la edición December 29, 2024 de The Business Guardian.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE The Business Guardian
The Business Guardian
INDIA RETAIL INFLATION TO AVERAGE 2.5% IN 2025-26 FISCAL
As the base effect on food fades, headline Consumer Price Index or retail inflation is likely to edge up slightly to average at 2.5 per cent this financial year 2025-26, Crisil has asserted.
1 mins
December 14, 2025
The Business Guardian
Sense of relief: Zubeen's uncle on SIT charge-sheet
CHARGE-SHEET FILED
1 mins
December 14, 2025
The Business Guardian
Nvidia eyes higher H200 chip output
Nvidia has told Chinese clients it is evaluating adding production capacity for its powerful H200 AI chips after orders exceeded its current output level, according to two sources briefed on the matter.
1 min
December 14, 2025
The Business Guardian
TARIFFS HAVE COST EACH U.S. HOUSEHOLD $1,200
Sweeping taxes on imports have cost the average American household nearly $1,200 since Donald Trump returned to the White House this year, according to calculations by Democrats on Congress’ Joint Economic Committee.
2 mins
December 14, 2025
The Business Guardian
CTA APPARELS HAILS INDIA-EU FTA PROGRESS
Indian garment manufacturer CTA Apparels has applauded the Government of India's encouraging progress on the India-EU Free Trade Agreement (FTA), with the blueprint now in advanced stages.
1 mins
December 14, 2025
The Business Guardian
Shiprocket files updated IPO papers, eyes Rs 2,342 cr issue
Temasek-backed e-commerce enablement platform Shiprocket has filed updated draft papers with markets regulator Sebi to raise a little over Rs 2,342 crore through its initial public offering (IPO).
1 mins
December 14, 2025
The Business Guardian
Azul gets court nod; US airlines to invest
A U.S. bankruptcy judge on Friday approved Azul's debt restructuring, allowing the Brazilian airline to slash more than $2 billion in debt and raise capital through a new equity rights offering and investment from American Airlines and United Airlines.
1 mins
December 14, 2025
The Business Guardian
SC refuses to entertain bail plea in Mumbai BMW hit-and-run case
The Supreme Court has refused to entertain the bail plea of Mihir Shah, the son of a former Shiv Sena leader, in the 2024 Mumbai BMW hit-and-run case, saying “these boys need to be taught a lesson”.
1 mins
December 14, 2025
The Business Guardian
HOW TO USE YOUR BODY WEIGHT TO GYM AT HOME TO STAY FIT
Gyms also carry risks such as equipment-related injuries, overexertion, slips and falls, hygiene issues, and poor ventilation.
5 mins
December 14, 2025
The Business Guardian
Huawei phone packs upgraded China chip
The Kirin 9030, the chip that powers Huawei Technologies' latest flagship Mate 80 series handset, has been manufactured by China's top foundry SMIC with an improved version of 7 nanometres, which is still behind TSMC and Samsung, Canadian research firm TechInsights said.
1 min
December 14, 2025
Listen
Translate
Change font size
